• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性手术后治疗前颞肌厚度对口腔鳞状细胞癌的预后价值。

Prognostic value of pretreatment temporal muscle thickness after curative surgery for oral cavity squamous cell carcinoma.

机构信息

Departments of Otolaryngology, Head and Neck Surgery, University of Tokyo, 7-3-1, Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.

Department of Otolaryngology, NTT Medical Center Tokyo, Tokyo, Japan.

出版信息

Int J Clin Oncol. 2024 Oct;29(10):1444-1450. doi: 10.1007/s10147-024-02591-3. Epub 2024 Jul 30.

DOI:10.1007/s10147-024-02591-3
PMID:39080115
Abstract

BACKGROUND

Sarcopenia is a poor prognostic factor in various diseases. Temporal muscle thickness (TMT) has been reported to be associated with sarcopenia. We investigated the prognostic value of TMT in patients with oral squamous cell carcinoma.

METHODS

This study included 61 patients with oral squamous cell carcinoma. Two board-certified otolaryngologists measured TMT based on pre-treatment CT. The following sex-specific TMT cut-off values were used in accordance with previous reports: ≤ 6.3 mm in men, and ≤ 5.2 mm in women. We classified patients into normal TMT group and low TMT group according to the cutoff values. The correlation between the TMT measurements of the two readers was tested using the interclass correlation coefficient (ICC). Cox regression models were used to verify the association between TMT and prognostic factors.

RESULTS

The low TMT group had a significantly lower BMI than the normal TMT group. Patients with low TMT at baseline had a significantly higher risk of death than those with normal TMT (hazard ratio 4.51; 95% confidence interval [CI] 1.49-13.61; p = 0.0076). There were no significant differences in disease-specific survival between the two groups. The correlation between the two evaluators' TMT measurements was excellent (ICC 0.988, 95% CI 0.981-0.933).

CONCLUSIONS

Sex-specific TMT was associated with overall survival in patients with oral squamous cell carcinoma. TMT is easy to assess and its measurement is consistent between evaluators.

摘要

背景

肌肉减少症是多种疾病的不良预后因素。有研究报道,颞肌厚度(TMT)与肌肉减少症相关。我们研究了 TMT 对口腔鳞状细胞癌患者的预后价值。

方法

本研究纳入了 61 例口腔鳞状细胞癌患者。两位经过认证的耳鼻喉科医生根据治疗前 CT 测量 TMT。根据既往研究报道,采用以下性别特异性 TMT 截断值:男性 TMT 截断值≤6.3mm,女性 TMT 截断值≤5.2mm。我们根据截断值将患者分为 TMT 正常组和 TMT 低组。采用组内相关系数(ICC)检验两位观察者 TMT 测量值的相关性。采用 Cox 回归模型验证 TMT 与预后因素的关系。

结果

TMT 低组的 BMI 显著低于 TMT 正常组。基线 TMT 低的患者死亡风险显著高于 TMT 正常的患者(风险比 4.51;95%置信区间 [CI] 1.49-13.61;p=0.0076)。两组间疾病特异性生存率无显著差异。两位评估者的 TMT 测量值相关性极好(ICC 0.988,95%CI 0.981-0.933)。

结论

性别特异性 TMT 与口腔鳞状细胞癌患者的总生存率相关。TMT 易于评估,评估者间测量值一致。

相似文献

1
Prognostic value of pretreatment temporal muscle thickness after curative surgery for oral cavity squamous cell carcinoma.根治性手术后治疗前颞肌厚度对口腔鳞状细胞癌的预后价值。
Int J Clin Oncol. 2024 Oct;29(10):1444-1450. doi: 10.1007/s10147-024-02591-3. Epub 2024 Jul 30.
2
Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma.颞肌厚度作为肌少症的指标可预测头颈部鳞状细胞癌的无进展生存期。
Sci Rep. 2021 Oct 5;11(1):19717. doi: 10.1038/s41598-021-99201-3.
3
Reliability and validity of measuring temporal muscle thickness as the evaluation of sarcopenia risk and the relationship with functional outcome in older patients with acute stroke.测量颞肌厚度作为评估急性中风老年患者肌肉减少症风险的可靠性和有效性及其与功能结局的关系
Clin Neurol Neurosurg. 2021 Feb;201:106444. doi: 10.1016/j.clineuro.2020.106444. Epub 2021 Jan 1.
4
A novel radiographic marker of sarcopenia with prognostic value in glioblastoma.一种具有预后价值的肌少症新型影像学标志物在胶质母细胞瘤中的应用。
Clin Neurol Neurosurg. 2021 Aug;207:106782. doi: 10.1016/j.clineuro.2021.106782. Epub 2021 Jun 24.
5
CT-assessed sarcopenia and prognostic nutritional index are associated with poor prognosis in oral squamous cell carcinoma.CT 评估的肌肉减少症和预后营养指数与口腔鳞状细胞癌的不良预后相关。
Oral Maxillofac Surg. 2024 Jun;28(2):659-666. doi: 10.1007/s10006-023-01191-1. Epub 2023 Nov 8.
6
Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosis.在诊断为胶质母细胞瘤的患者中,颞肌厚度作为肌少症标志物的预后相关性。
Eur Radiol. 2021 Jun;31(6):4079-4086. doi: 10.1007/s00330-020-07471-8. Epub 2020 Nov 17.
7
Correlation of reduced temporal muscle thickness and systemic muscle loss in newly diagnosed glioblastoma patients.新诊断的胶质母细胞瘤患者颞肌厚度减少与全身肌肉减少的相关性。
J Neurooncol. 2022 Dec;160(3):611-618. doi: 10.1007/s11060-022-04180-8. Epub 2022 Nov 17.
8
Temporalis muscle thickness as a predictor of functional outcome after reperfusion therapies for acute ischemic stroke: a retrospective, cohort study.颞肌厚度作为急性缺血性中风再灌注治疗后功能预后的预测指标:一项回顾性队列研究。
J Neurol. 2024 Sep;271(9):6015-6024. doi: 10.1007/s00415-024-12575-y. Epub 2024 Jul 19.
9
Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases.利用头颅磁共振成像测量颞肌厚度对新诊断脑转移瘤患者进行生存预测。
Eur Radiol. 2017 Aug;27(8):3167-3173. doi: 10.1007/s00330-016-4707-6. Epub 2017 Jan 3.
10
The possible relation between temporal muscle mass and glioblastoma multiforme prognosis via sarcopenia perspective.从肌肉减少症角度探讨颞肌质量与胶质母细胞瘤患者预后的可能关系。
Turk J Med Sci. 2023 Feb;53(1):413-419. doi: 10.55730/1300-0144.5599. Epub 2023 Feb 22.

引用本文的文献

1
Temporal muscle thickness as a feasible sarcopenia marker and outcome predictor after aneurysmal subarachnoid hemorrhage.颞肌厚度作为动脉瘤性蛛网膜下腔出血后可行的肌肉减少症标志物和预后预测指标。
Acta Neurochir (Wien). 2025 May 29;167(1):157. doi: 10.1007/s00701-025-06562-z.

本文引用的文献

1
Immune-modified Glasgow prognostic score: A new prognostic marker for head and neck cancer.免疫改良格拉斯哥预后评分:一种用于头颈癌的新预后标志物。
Head Neck. 2022 Nov;44(11):2555-2563. doi: 10.1002/hed.27170. Epub 2022 Aug 23.
2
Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071-22072 and CORE Trials.颞肌厚度作为新诊断胶质母细胞瘤患者的预后标志物:CENTRIC EORTC 26071-22072 和 CORE 试验的转化影像学分析。
Clin Cancer Res. 2022 Jan 1;28(1):129-136. doi: 10.1158/1078-0432.CCR-21-1987. Epub 2021 Oct 19.
3
Prognostic Role of Preoperative Sarcopenia Evaluation of Cervical Muscles with Long-Term Outcomes of Patients with Oral Squamous Cell Carcinoma.
术前颈肌少肌症评估对口腔鳞状细胞癌患者长期预后的作用
Cancers (Basel). 2021 Sep 21;13(18):4725. doi: 10.3390/cancers13184725.
4
Evaluation of Sarcopenia in Older Patients Undergoing Head and Neck Cancer Surgery.评估行头颈部癌症手术的老年患者的肌肉减少症。
Laryngoscope. 2022 Feb;132(2):356-363. doi: 10.1002/lary.29782. Epub 2021 Aug 12.
5
Temporal muscle thickness and area are an independent prognostic factors in patients aged 75 or younger with aneurysmal subarachnoid hemorrhage treated by clipping.对于75岁及以下接受夹闭术治疗的动脉瘤性蛛网膜下腔出血患者,颞肌厚度和面积是独立的预后因素。
Surg Neurol Int. 2021 Apr 14;12:151. doi: 10.25259/SNI_814_2020. eCollection 2021.
6
A change in temporal muscle thickness is correlated with past energy adequacy in bedridden older adults: a prospective cohort study.时间肌厚度的变化与卧床老年人大脑既往能量充足程度相关:一项前瞻性队列研究。
BMC Geriatr. 2021 Mar 15;21(1):182. doi: 10.1186/s12877-021-02086-0.
7
Reliability and validity of measuring temporal muscle thickness as the evaluation of sarcopenia risk and the relationship with functional outcome in older patients with acute stroke.测量颞肌厚度作为评估急性中风老年患者肌肉减少症风险的可靠性和有效性及其与功能结局的关系
Clin Neurol Neurosurg. 2021 Feb;201:106444. doi: 10.1016/j.clineuro.2020.106444. Epub 2021 Jan 1.
8
Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength Evaluation.神经科患者的肌肉减少症:颞肌厚度和肌肉力量评估的标准值
J Clin Med. 2020 Apr 28;9(5):1272. doi: 10.3390/jcm9051272.
9
Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy.肌肉减少症对头颈部癌症患者放疗后生存和晚期毒性的影响。
Radiother Oncol. 2020 Jun;147:103-110. doi: 10.1016/j.radonc.2020.03.014. Epub 2020 Apr 3.
10
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment.亚洲肌少症工作组:2019年肌少症诊断与治疗共识更新
J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012. Epub 2020 Feb 4.